Recent Finacing
Recent Raise
Fibrocor Therapeutics develops disease‑modifying anti‑fibrotic drugs using a tissue‑based discovery platform that identifies novel targets and pathways from well‑annotated patient samples, partnering with Evotec for drug discovery.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor